Non-cancerous enlargement of the prostate, common enough that roughly half of men in their fifties have it. It is not cancer and does not become cancer. It is also the condition with the best-selling supplement in men's health, and saw palmetto failed to beat placebo in two of the most rigorous trials ever run on it.
Last updated:
Growth of the prostate gland with age, which squeezes the urethra running through it and obstructs the flow of urine. The bladder then has to work harder, and over time becomes thickened and irritable, which is why the symptoms are a mix of poor flow and urgency rather than one or the other.
It is benign. It is not prostate cancer, it does not turn into prostate cancer, and having it does not raise your risk of it. The two can coexist simply because both are common with age, which is why symptoms still need assessing rather than assuming.
Prostate size correlates poorly with symptoms. A large prostate can cause little trouble and a modest one can cause a great deal, so treatment follows how much it is affecting you rather than a measurement.
Two rigorous randomised trials, one escalating the dose, found no benefit over placebo12. It remains the best-selling product for this condition.
Symptom severity was associated with metabolic syndrome, and with the number of its components present3. That is where the modifiable ground is.
Benign enlargement does not become prostate cancer. Both are common with age, so symptoms are still assessed. See prostate cancer.
In two groups, and most men have some of each.
| Feature | What it looks like | Worth knowing |
|---|---|---|
| Weak or slow stream | Taking longer, less force than it used to have | An obstructive symptom. Usually the earliest and most gradual |
| Hesitancy, straining, stopping and starting | Waiting for it to begin, or it stalling mid-flow | Also obstructive, and often adapted to before it is reported |
| Dribbling at the end | Continuing after you think you have finished | Very common and rarely mentioned unprompted |
| Getting up at night to pass urine | Once, twice, or more | Often the symptom that finally prompts a visit, because it wrecks sleep. See insomnia |
| Urgency and frequency | Needing to go suddenly, and often | From the bladder becoming irritable, not from the prostate directly. It can persist after the obstruction is treated |
| Feeling the bladder has not emptied | Going again shortly afterwards | Worth reporting, since retained urine raises infection and stone risk |
| Complete inability to pass urine, painful full bladder | Sudden, distressing | Emergency. Acute urinary retention needs same-day treatment |
| Blood in the urine, fever, or weight loss | Anything on this row | Not typical of simple BPH. Report it and have it assessed |
By how much it is affecting you, plus a short list of things that must be excluded.
| Measure | What it tells you | What it misses |
|---|---|---|
| A symptom score | How severe it is and whether treatment is helping, in a number you can track | Does not distinguish prostate obstruction from bladder overactivity, which behave differently |
| A bladder diary | What is actually happening, including how much you drink and when | Frequently more useful than any test, and almost never suggested |
| Urine dipstick and culture | Infection, blood, glucose | Blood in the urine needs following up regardless of BPH |
| Post-void residual | Whether the bladder is emptying | Varies between measurements, so one high reading is not a verdict |
| Examination of the prostate | Size and texture, and anything that feels irregular | Size correlates poorly with symptoms, which surprises people |
| PSA, as a shared decision | Part of assessing whether cancer is also present | Enlargement itself raises PSA, and some BPH medicines lower it, so results need interpreting in context. Discuss the pros and cons; see prostate cancer |
| Kidney function | Whether long-standing obstruction has affected the kidneys | See chronic kidney disease |
| Glucose, blood pressure, lipids, waist | The metabolic picture associated with symptom severity3 | Rarely connected to the urinary complaint, and it is where the modifiable ground is. See metabolic syndrome |
Fluid timing, the metabolic picture, and honesty about the supplements
Mostly about when you drink, and about the metabolic picture underneath.
| Change | Why | Practical note |
|---|---|---|
| Move fluid earlier in the day | Directly reduces night-time waking | Keep the daily total. Stop two to three hours before bed |
| Do not cut total fluid | Concentrated urine irritates the bladder and raises infection and stone risk | The commonest self-treatment, and it usually makes things worse. See kidney stones |
| Less evening alcohol | Increases urine production and worsens the night | The single change most men notice fastest |
| Less caffeine, especially after midday | Bladder irritant and a diuretic | Reduce gradually to avoid withdrawal headaches |
| Weight and waist | Part of the metabolic picture associated with severity3 | Gradual. See obesity |
| Regular physical activity | Consistently associated with fewer urinary symptoms | Walking counts. It does not need to be strenuous |
| Enough fibre to avoid constipation | A loaded rectum worsens bladder emptying | Increase gradually, with fluid |
| A vegetable-forward pattern | Serves the metabolic and cardiovascular picture that travels with this | Sensible rather than proven for the prostate itself, and presented that way |
A short and mostly negative section, which is the honest state of this field.
| Supplement | What it is actually for | Typical range | Timing | Notes & cautions |
|---|---|---|---|---|
| Saw palmetto | Not supported. A trial escalating the dose found no reduction in symptoms beyond placebo1, and an earlier rigorous trial found no improvement over placebo2. | Listed to answer the question, not to recommend it | Not applicable | The most heavily sold product for this condition, tested more carefully than most supplements ever are, and it did not work. Generally well tolerated, so the main cost is money and delay. |
| Beta-sitosterol and pygeum | Older and smaller trials suggested symptom improvement; the evidence is weaker and less consistent than the saw palmetto evidence that turned out negative. | Discuss with your clinician rather than self-selecting | With food | Presented honestly rather than recommended. The saw palmetto story is a caution about how promising early results in this field have read. |
| Weight loss and activity | The metabolic picture associated with symptom severity3, and not a supplement. | Gradual, and sustainable | Not applicable | In this table deliberately, because it has more behind it than anything sold in a bottle for this condition. |
| Zinc and testosterone products | Not supported for BPH, and testosterone in particular needs medical supervision for other reasons. | Not recommended for this purpose | Not applicable | Marketed heavily to men through prostate and vitality products. Discuss anything hormonal with a clinician rather than buying it. |
Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.
Last reviewed 3 September 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.4 This page is nutrition education, not medical advice, and it does not replace your doctor. No supplement has been shown to treat benign prostatic hyperplasia in a rigorous trial, and the most widely sold one failed to beat placebo in two. Benign enlargement is not prostate cancer and does not become it, but symptoms still need assessing, and blood in the urine, fever, or inability to pass urine are not part of simple enlargement. What nutrition education can do is help you understand the evidence well enough to have a better conversation with the clinician who does treat you.